3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
3
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2
Non Small Cell Lung Carcinoma NSCLC
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Triple Negative Breast Neoplasms
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Endocrine System Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
pembrolizumab
15
Paclitaxel
15
Carboplatin
13
Specimen Handling
6
Biopsy
6
durvalumab
5
Magnetic Resonance Spectroscopy
5
dostarlimab
4
Taxes
4
Surveys and Questionnaires
4
Observation
4
Letrozole
4
Everolimus
4
Cisplatin
4
olaparib
3
lenvatinib
3
ceralasertib
3
Doxorubicin
3
sacituzumab govitecan
2
pertuzumab
2
copanlisib
2
cabozantinib
2
atezolizumab
2
abemaciclib
2
Trastuzumab
2
Robotic Surgical Procedures
2
Pemetrexed
2
Nivolumab
2
Metformin
2
Megestrol Acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Endometrial Neoplasms
×
CP protocol
×
Clear all
NCT05201547
2025-12-04
DOMENICA
ARCAGY/ GINECO GROUP
Phase 3
Active not recruiting
260 enrolled